Skip Navigation



European Heart Journal Advance Access published online on June 29, 2007

European Heart Journal, doi:10.1093/eurheartj/ehm246
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/18/2223    most recent
ehm246v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Range, F. T.
Right arrow Articles by Wichter, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Range, F. T.
Right arrow Articles by Wichter, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Impaired myocardial perfusion and perfusion reserve associated with increased coronary resistance in persistent idiopathic atrial fibrillation

Felix T. Range1,2, Michael Schäfers1,3,*,{dagger}, Tayfun Acil2, Klaus P. Schäfers1, Peter Kies1,3, Matthias Paul2, Sven Hermann1, Betty Brisse2, Günter Breithardt2, Otmar Schober1 and Thomas Wichter2,3

1 Department of Nuclear Medicine, University of Münster, Albert-Schweitzer-Str. 33, D-48149 Münster, Germany
2 Department of Cardiology and Angiology, University of Münster, Germany
3 Interdisciplinary Centre of Clinical Research (IZKF), University of Münster, Germany

Received 20 February 2007; revised 7 May 2007; accepted 22 May 2007.

* Corresponding author. Tel: +49 251 83 47362; fax: +49 251 83 47363. E-mail address: schafmi{at}uni-muenster.de

Aims: Patients with atrial fibrillation (AF) present with symptoms of myocardial ischaemia despite exclusion of coronary artery disease. A small vessel disease has been suggested. We quantified myocardial perfusion, perfusion reserve, and coronary vascular resistance (CVR) in AF patients using positron emission tomography (PET).

Methods and results: Twenty-five male patients (age: 58 ± 13 years) with persistent idiopathic AF were compared with 13 age- and risk-matched male controls (age: 56 ± 8 years). Using H215O-PET, myocardial blood flow (MBF) was quantified at rest, at hyperaemia (adenosine), and during cold-pressor-testing (CPT). Scans were repeated 4.1 ± 2.3 months after cardioversion in 10 AF patients. In AF, resting MBF (0.95 ± 0.19 vs. 1.14 ± 0.22 mL/min/mL; P = 0.009), hyperaemic MBF (2.07 ± 0.80 vs. 3.33 ± 0.78 mL/min/mL; P < 0.001), and MBF under CPT (0.90 ± 0.25 vs. 1.14 ± 0.25 mL/min/mL; P < 0.014) were significantly reduced compared with matched controls. Hyperaemic CVR was increased in AF (47 ± 21 vs. 29 ± 7 mmHg x mL/min/mL; P = 0.012) but unchanged at rest and under CPT. After cardioversion, resting MBF and MBF under CPT in AF were similar to matched controls, however, hyperaemic MBF and CVR were not recovered.

Conclusion: In AF, MBF at baseline, at hyperaemia, and at CPT is reduced, whereas CVR under hyperaemic conditions is increased. Following electrical cardioversion, these findings are partly reversible and therefore most likely secondary to the arrhythmia.

Key Words: Atrial fibrillation • Myocardial perfusion • Myocardial blood flow • Coronary vascular resistance • Positron emission tomography


{dagger} The first two authors have contributed equally.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EuropaceHome page
P. Kirchhof, J. Bax, C. Blomstrom-Lundquist, H. Calkins, A. J. Camm, R. Cappato, F. Cosio, H. Crijns, H.-C. Diener, A. Goette, et al.
Early and comprehensive management of atrial fibrillation: Proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'
Europace, July 1, 2009; 11(7): 860 - 885.
[Full Text] [PDF]


Home page
Eur Heart JHome page
A. Goette, A. Bukowska, D. Dobrev, J. Pfeiffenberger, H. Morawietz, D. Strugala, I. Wiswedel, F.-W. Rohl, C. Wolke, S. Bergmann, et al.
Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles
Eur. Heart J., June 1, 2009; 30(11): 1411 - 1420.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
F. T. Range, M. Paul, K. P. Schafers, T. Acil, P. Kies, S. Hermann, O. Schober, G. Breithardt, T. Wichter, and M. A. Schafers
Myocardial Perfusion in Nonischemic Dilated Cardiomyopathy With and Without Atrial Fibrillation
J. Nucl. Med., March 1, 2009; 50(3): 390 - 396.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. Bukowska, U. Lendeckel, A. Krohn, G. Keilhoff, S. t. Have, K. H. Neumann, and A. Goette
Atrial fibrillation down-regulates renal neutral endopeptidase expression and induces profibrotic pathways in the kidney
Europace, October 1, 2008; 10(10): 1212 - 1217.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. C. Haigney
Reduced myocardial perfusion in atrial fibrillation: when the egg comes before the chicken
Eur. Heart J., September 2, 2007; 28(18): 2181 - 2182.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.